| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| follitropin alfa 450 units (33 microgram)/0.75 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 225 units (16.5 microgram)/0.375 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 150 units (11 microgram)/0.25 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 22 microgram / 0.5 mL injection, 0.5 mL pen device (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pemetrexed 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ceftolozane 1 g + tazobactam 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| liraglutide 6 mg/mL injection, 3 mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| docetaxel 160 mg / 8 mL injection, 8 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| cisatracurium 20 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| cisatracurium 50 mg/25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ibuprofen 800 mg/8 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ibuprofen 400 mg/4 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| esmolol hydrochloride 2.5 g/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| fentanyl 250 microgram / 5 mL injection, 5 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| honey bee venom 550 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| paper wasp venom 550 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| yellow jacket venom 550 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nivolumab 100 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nivolumab 40 mg/4 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| cyanocobalamin 20 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| talimogene laherparepvec 1 million PFU/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| tocilizumab 162 mg/0.9 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| talimogene laherparepvec 100 million PFU/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| blinatumomab 38.5 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 9500 anti-Xa units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 5700 anti-Xa units/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 3800 anti-Xa units/0.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 7600 anti-Xa units/0.8 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 2850 anti-Xa units/0.3 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 1900 anti-Xa units/0.2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 15 200 anti-Xa units/0.8 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 11 400 anti-Xa units/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nadroparin calcium 19 000 anti-Xa units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| mepolizumab 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza quadrivalent adult vaccine 2016 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza quadrivalent child vaccine 2016 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 16 g/100 mL + soya oil 4 g/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 40 g/250 mL + soya oil 10 g/250 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 80 g/500 mL + soya oil 20 g/500 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 10 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ifosfamide 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vindesine sulfate 5 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 1 g/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 4 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 2 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ustekinumab 90 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| noradrenaline (norepinephrine) 1 in 1000 (4 mg/4 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 56 g/350 mL + soya oil 14 g/350 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| levetiracetam 500 mg/100 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| apomorphine hydrochloride hemihydrate 50 mg/10 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| thiopental sodium 470 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxycodone hydrochloride 200 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| methotrexate 15 mg/0.3 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| methotrexate 10 mg/0.2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| methotrexate 25 mg/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| methotrexate 20 mg/0.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| methotrexate 7.5 mg/0.15 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide phosphate 567.8 mg (etoposide 500 mg) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide phosphate 113.6 mg (etoposide 100 mg) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide phosphate 1.136 g (etoposide 1 g) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lipegfilgrastim 6 mg/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| levomepromazine hydrochloride 25 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| alteplase 20 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pralatrexate 20 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ocriplasmin 500 microgram/0.2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pralatrexate 40 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| evolocumab 140 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| evolocumab 140 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| clindamycin 300 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adenosine 90 mg/30 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adenosine 60 mg/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| colistin 150 mg (4.5 million units) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adenosine 6 mg/2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lanreotide 90 mg/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lanreotide 60 mg/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lanreotide 120 mg/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| levetiracetam 1 g/100 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| levetiracetam 1.5 g/100 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| smallpox live vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| rabies vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Japanese encephalitis live vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Q fever vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Coxiella burnetii antigen 2.5 microgram/0.5 mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| yellow fever live vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Japanese encephalitis (vero cell-derived) inactivated vaccine injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| Mycobacterium bovis (BCG) live vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Japanese encephalitis (mouse brain-derived) inactivated vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| meningococcal B 4 component vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| human papillomavirus quadrivalent vaccine injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| human papillomavirus quadrivalent vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| human papillomavirus bivalent vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| insulin glargine 100 units/mL injection, 3 mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A + hepatitis B adult vaccine injection, 1 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A + hepatitis B child vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A child/adolescent vaccine 720 ELISA units/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A adult vaccine 50 units/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A adult vaccine 1440 ELISA units/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A adult vaccine 1440 ELISA units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A child/adolescent vaccine 720 ELISA units/0.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis A child/adolescent vaccine 25 units/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|